Related Articles
Research
HC Wainwright Downgrades Cardiff Oncology to Neutral From Buy
Cardiff Oncology (CRDF) has an average rating of buy and mean price target of $8.36, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$CRDF
Research
Raymond James Initiates HawkEye 360 at Strong Buy With $40 Price Target
$HAWK
Research
Jefferies Initiates Hawkeye 360 at Hold With $34 Price Target
$HAWK